Which mineral abnormality is most associated with renal osteodystrophy?

Prepare for the Fresenius Nurse Test. Get comprehensively prepared with flashcards and multiple choice questions. Each question includes hints and explanations. Achieve success on your exam today!

Multiple Choice

Which mineral abnormality is most associated with renal osteodystrophy?

Explanation:
Renal osteodystrophy arises from disturbances in mineral metabolism caused by chronic kidney disease. The mineral abnormality most associated is hyperphosphatemia. When the kidneys can’t excrete phosphate effectively, phosphate builds up in the blood. This excess phosphate binds calcium, lowering serum calcium and triggering the parathyroid glands to release more parathyroid hormone (secondary hyperparathyroidism). The resulting high PTH causes increased bone turnover and resorption, leading to the bone changes seen in renal osteodystrophy. While calcium levels can vary and hypercalcemia may occur with treatment, the underlying link to this bone disorder is the elevated phosphate level. Hyponatremia has no direct role in renal osteodystrophy. Management aims to lower phosphate through diet, phosphate binders, and dialysis, along with calcium and vitamin D strategies to control PTH.

Renal osteodystrophy arises from disturbances in mineral metabolism caused by chronic kidney disease. The mineral abnormality most associated is hyperphosphatemia. When the kidneys can’t excrete phosphate effectively, phosphate builds up in the blood. This excess phosphate binds calcium, lowering serum calcium and triggering the parathyroid glands to release more parathyroid hormone (secondary hyperparathyroidism). The resulting high PTH causes increased bone turnover and resorption, leading to the bone changes seen in renal osteodystrophy. While calcium levels can vary and hypercalcemia may occur with treatment, the underlying link to this bone disorder is the elevated phosphate level. Hyponatremia has no direct role in renal osteodystrophy. Management aims to lower phosphate through diet, phosphate binders, and dialysis, along with calcium and vitamin D strategies to control PTH.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy